Last update 23 Nov 2024

OPA-6566

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
OPA 6566
Target
A2aR
Mechanism
A2aR agonists(Adenosine A2a receptor agonists)
Therapeutic Areas
Eye Diseases
Active Indication-
Inactive Indication
Glaucoma, Open-AngleOcular Hypertension
Originator Organization
Otsuka Holdings Co., Ltd.
Active Organization-
Inactive Organization
Acucela, Inc.Acucela, Inc.Otsuka Holdings Co., Ltd.
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with OPA-6566
NCT01410188 / CompletedPhase 1/2
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
100 Clinical Results associated with OPA-6566
Login to view more data
100 Translational Medicine associated with OPA-6566
Login to view more data
100 Patents (Medical) associated with OPA-6566
Login to view more data
100 Deals associated with OPA-6566
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AnglePhase 2
US
-01 Sep 2011
Ocular HypertensionPhase 2
US
Acucela, Inc.Acucela, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free